Nilendu Purandare

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer

Vanita Noronha, Vijay Patil, Amit Joshi et al. · Journal of Clinical Oncology · 2019 · 421 citations

Medicine, Oncology, Pharmacology +15

EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted Therapy

Vanita Noronha, Kumar Prabhash, Abhishek Thavamani et al. · PLoS ONE · 2013 · 83 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

Vijay Patil, Vanita Noronha, Amit Joshi et al. · ESMO Open · 2017 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC Patients

Vanita Noronha, Amit Joshi, Anant Gokarn et al. · Chemotherapy Research and Practice · 2014 · 33 citations · Full text

Medicine, Genetics, Oncology +14

Radiation Therapy Dose Escalation in Unresectable Ewing Sarcoma: Final Results of a Phase 3 Randomized Controlled Trial

Siddhartha Laskar, Shwetabh Sinha, Abhishek Chatterjee et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 30 citations

Medicine, Oncology, Radiation Oncology +16